EUCTR2006-004878-28-NL进行中（未招募）1 期
Does caffeine reduce dipyridamole-induced protection against ischemia-reperfusion injury?
MCN farm-tox0 个研究点目标入组 20 人开始时间: 2007年6月14日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •-healthy male volunteers
- •-aged 18-50 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-cardiovascular disease
- •-hypertension (systole > 140 mmHg, diastole > 90 mmHg)
- •-hypercholesterolemia (fasting total cholesterol > 5 mmol/l)
- •-diabetes mellitus (fasting glucose > 7.0 mmol/L or random glucose > 11.0 mmol/L)
- •-asthma (recurrent episodes of dyspnea and wheezing, or usage of prescribed inhalation medication: i.e. corticosteroids or B2-agonists)
- •-participation in any clinical trial during the last 60 days prior to this study.
- •-administration of two doses of Annexin A5 (0,1mg; 450MBq) during the last 5 years prior to this study.
研究者
相似试验
尚未招募
不适用
Does caffeine reduce dipyridamole-induced protection against ischemia-reperfusion injury?infarctionischemic reperfusion injury10003216NL-OMON30237niversitair Medisch Centrum Sint Radboud20
已完成
4 期
Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?Ischemia-Reperfusion InjuryCardiovascular DiseaseNCT00430170Radboud University Medical Center20
已完成
不适用
The effect of acute caffeine consumption on performance and brain activity following a *real-life* workdayburnoutlife-long learning10009841NL-OMON35704niversiteit Maastricht20
已完成
不适用
Effect of caffeine supplementation on physical performance and oxidative stress during high-intensity exercisesCaffeineD03.132.960.175RBR-52twggniversidade Federal do Paraná
招募中
2 期
The effects of caffeine supplementation on clinical parameters and disease severity in patients with hepatic cirrhosisIRCT20100524004010N34Shahid Beheshti University of Medical Sciences25